HLA-DQ7

Serology

Serotyping efficiency. The serotyping efficiency of DQ7 toward DQB1*0301 is reasonably good, but still results in some false negatives, for *0304 the typing efficiency is poor and cross-reaction with DQ8 is relatively high.

Alleles

DQB1*0301

DQB10301 is the major DQ7 allele **DQB10301** appears to be associated with lupus anticoagulant.

DQB1*0304

DQB1*0304 is the minor DQ7 allele

Haplotypes

DQ haplotypes of this serotype are formed between the cis-chromosomal genes of the DQA1 locus. This includes DQA1*0301, *0302, *0303, *0401, *0505, *0601.

There is a rather large degree of disequilibration about DQA10301 suggesting that this is one of the older and more established HLA DQB1 alleles in Eurasia. The intron structure of DQB1 suggest that DQB10301 DQB10302/0303 split occurred before DQB10302/0303, the distribution of 03 in Africa suggest that recombination DQA103:DQB10301 are primarily the result of recombination events that have occurred in Africa. A recent study of myasthenia gravis in Houston confirms the presence of A0505:B0301 in Nigeria. B10301 and A103 haplotypes are found at relatively high frequencies in SE Asia and Austronesia, also indicating that it is well established in the exo-African population.

DQ7.3

The DQ7.3 haplotype can be formed by DQA10301:DQB10301, DQA10302:DQB10301, DQA10303:DQB10301. In the west, the DQA10303:DQB10301 haplotype appears to be more common. The gene products of all 3 function similarly and subunits are interchangeable. In the literature, older DNA tests recognize DQA10303 as DQA10302, and still oldest DNA tests recognize all three as DQA103 or DQA10301.

DQA10303:DQB10301 may be involved in narcolepsy. DQ7.3 appears to be associated with oral ulcerations and gingival disease

DQ7.4

DQA10401:DQB10301 (DQ7.4) This haplotype is found in Siberia, Africa but also at low levels in Western Europe.

DQ7.5

DQA10505:DQB10301 (DQ7.5) was gene-typed as DQA10501:DQB10301 until it was recognized that there was amino acid sequence variant in the preprocessed DQA1* gene product (proto-α-chain polypeptide encoded DQA10505). This proto-alpha, once processed, is identical to the DQA10501 encoded α-chain once it is processed. Almost 100% of DQ7.5 haplotypes carry the DQA1*0505 allele. The DR5-DQ7.5 is common in the Southeastern Europe and the Levant, with DQ7.5 reaching a haplotype frequency of 40% in Lebanon. Its high level is probably not by chance, the haplotype appears to protect against juvenile diabetes, which appears to be more common among cereal eating peoples. Cereals were first domesticated in the Near and Middle East more than 10,000 years ago and selection may explain DQ7.5's higher frequencies. (See: Triticeae)

The processed alpha subunit of DQA10505 is identical to that of DQA10501, but some slight differences in the association with autoimmune disease are observed, possibly as a result of linked DR and DQB1 genes. DQA10505 can play into celiac disease under two circumstances. First it can increase risk when DQ2.5 is present, although current studies indicate that it marginally increases risk relative to DQB10202 in DQ2.5 cis haplotype. DQA1*0505, without DQ2, is found in a small percentage of coeliac disease (without DQ2 or DQ8).

DQ7.5 is found also high in frequency in the new world, but with DR types less commonly encountered in the old world. DQA105 allele is not clear in the new world. DQB10301 may be under current positive selection in the human population, at least in areas where DQ2.5 and DQ8 are high, as it confers resistance to type 1 diabetes. For hepatitis type B, DQ7 is associated with persistence but for C, DQ7 is associated with clearance. DQA10505, DQB10301 appear to increase the risk for melanoma in the Spanish population however this may have a linkage to more recent fair skinned migrants. DQB10301 is also associated with allergic fungal sinusitis, human papillomavirus (HPV) induced warts, limited cutaneous systemic sclerosis in Africans, and primary sclerosing cholangitis in Southern Europeans. DQB10301 is also predisposing in narcolepsy. DQB1*0301 does not to play a role in any frequently occurring autoimmune disease and its presence in the near east and suppressed frequencies of coeliac disease and Type 1 diabetes in these regions is suggestive that it has a positive selection in Post-Mesolithic cereal based societies in the Western Eurasia.

DQB10301 appears to be more associated with early onset myasthenia gravis in Japanese than DQ8, and was also found along with DQB10304 to be associated with Chinese MG. DQ7 or associated DR types may play a role in rheumatoid arthritis. In celiac disease the DQ7 (A0505/1) can mediate celiac disease when HLA DQ2.2 is also present. HLA DQB10301 in Turks is associated with Thymoma but the risk may be associated with HLA class I loci.

DQ7.6

DQA10601:DQB10301 (DQ7.6) is a globally rare haplotype, however it is found at high frequencies in the South Pacific and along the West Pacific rim. DQB10301 appears to be uniquely linked to DQA10601. DQ7.6 is positively associated with asthma, pauciarticular juvenile arthritis without anti-nuclear antibodies, DQ7.6 is negatively associated (Protective against) juvenile diabetes, liver and spleen disease in Schistosoma japonicum infection, pulmonary tuberculosis.

References

References

1. (1993). "Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP)". Hum. Immunol..
2. [https://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]
3. (1991). "Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant". J. Clin. Invest..
4. (2007). "DQB10301 and DQB10601 modulate narcolepsy susceptibility in Koreans". Hum. Immunol..
5. (Aug 1994). "Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.". Proc Natl Acad Sci U S A.
6. (2003). "New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans". Tissue Antigens.
7. (2003). "New allele frequency database". Tissue Antigens.
8. (2000). "Novel associations among HLA-DQA1 and -DQB1 alleles, revealed by high-resolution sequence-based typing (SBT)". Tissue Antigens.
9. (2006). "Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon". Clin. Vaccine Immunol..
10. (2003). "HLA types in celiac disease patients not carrying the DQA105-DQB102 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease". Hum. Immunol..
11. (2007). "A comparative review of HLA associations with hepatitis B and C viral infections across global populations". World J. Gastroenterol..
12. (2001). "[Association between asthma and the polymorphism of HLA-DQ genes]". Zhonghua Jie He He Hu Xi Za Zhi.
13. (1995). "Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype". Br. J. Rheumatol..
14. (1995). "HLA DQA1 genotypes and its interaction with HLA DQB1 in Chinese IDDM living in Taiwan". Proc. Natl. Sci. Counc. Repub. China B.
15. (1998). "HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum". Int. J. Parasitol..
16. (2002). "Associations of HLA class II alleles with pulmonary tuberculosis in Thais". Eur. J. Immunogenet..